Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Equity (Unaudited)

v3.22.1
Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid In Capital
Accumulated Deficit
Total Akoustis Technologies, Inc. Equity
Noncontrolling Interest
Total
Balance at Jun. 30, 2020 $ 38 $ 145,072 $ (103,615) $ 41,495 $ 41,495
Balance (in Shares) at Jun. 30, 2020 37,990          
Common stock issued for cash, net of issuance costs $ 6 75,618 75,624 75,624
Common stock issued for cash, net of issuance costs (in Shares) 6,294          
Common stock issued in note conversion $ 5 25,265 25,270 25,270
Common stock issued in note conversion (in Shares) 4,984          
Stock-based compensation $ 1 6,083 6,084 6,084
Stock-based compensation (in Shares) 574          
Common stock issued for exercise of warrants 1,109 1,109 1,109
Common stock issued for exercise of warrants (in Shares) 219          
Common stock issued for exercise of options 1,270 1,270 1,270
Common stock issued for exercise of options (in Shares) 209          
ESPP purchase 204 204 204
ESPP purchase (in Shares) 32          
Common stock issued in payment of note interest 609 609 609
Common stock issued in payment of note interest (in Shares) 72          
Net loss (34,035) (34,035) (34,035)
Balance at Mar. 31, 2021 $ 50 255,230 (137,650) 117,630 117,630
Balance (in Shares) at Mar. 31, 2021 50,374          
Balance at Dec. 31, 2020 $ 41 173,918 (127,475) 46,484 46,484
Balance (in Shares) at Dec. 31, 2020 41,399          
Common stock issued for cash, net of issuance costs $ 4 52,198 52,202 52,202
Common stock issued for cash, net of issuance costs (in Shares) 3,582          
Common stock issued in note conversion $ 5 25,265 25,270 25,270
Common stock issued in note conversion (in Shares) 4,984          
Stock-based compensation 1,991 1,991 1,991
Stock-based compensation (in Shares) 96          
Common stock issued for exercise of warrants 991 991 991
Common stock issued for exercise of warrants (in Shares) 187          
Common stock issued for exercise of options 746 746 746
Common stock issued for exercise of options (in Shares) 118          
Common stock issued in payment of note interest 121 121 121
Common stock issued in payment of note interest (in Shares) 8          
Net loss (10,175) (10,175) (10,175)
Balance at Mar. 31, 2021 $ 50 255,230 (137,650) 117,630 117,630
Balance (in Shares) at Mar. 31, 2021 50,374          
Balance at Jun. 30, 2021 $ 51 265,130 (147,771) 117,410 117,410
Balance (in Shares) at Jun. 30, 2021 51,236          
Common stock issued for cash, net of issuance costs $ 3 25,627 25,630 25,630
Common stock issued for cash, net of issuance costs (in Shares) 3,644          
Stock-based compensation $ 1 7,753 7,754 7,754
Stock-based compensation (in Shares) 662          
Common stock issued for exercise of warrants 67 67 67
Common stock issued for exercise of warrants (in Shares) 21          
Common stock issued for exercise of options 369 369 369
Common stock issued for exercise of options (in Shares) 72          
ESPP purchase $ 1 311 312 312
ESPP purchase (in Shares) 53          
Common stock issued in acquisition 2,297 2,297 2,297
Common stock issued in acquisition (in Shares) 263          
Noncontrolling interest acquired 7,523 7,523
Net loss (42,799) (42,799) (121) (42,920)
Balance at Mar. 31, 2022 $ 56 301,554 (190,570) 111,040 7,402 118,442
Balance (in Shares) at Mar. 31, 2022 55,951          
Balance at Dec. 31, 2021 $ 55 291,969 (175,884) 116,140 7,528 123,668
Balance (in Shares) at Dec. 31, 2021 54,660          
Common stock issued for cash, net of issuance costs $ 1 6,840 6,841 6,841
Common stock issued for cash, net of issuance costs (in Shares) 1,158          
Stock-based compensation 2,506 2,506 2,506
Stock-based compensation (in Shares) 69          
Common stock issued for exercise of warrants 10 10 10
Common stock issued for exercise of warrants (in Shares) 12          
Common stock issued for exercise of options 229 229 229
Common stock issued for exercise of options (in Shares) 52          
Noncontrolling interest acquired 13 13
Net loss (14,686) (14,686) (139) (14,825)
Balance at Mar. 31, 2022 $ 56 $ 301,554 $ (190,570) $ 111,040 $ 7,402 $ 118,442
Balance (in Shares) at Mar. 31, 2022 55,951